• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估一项培训干预措施,以改善津巴布韦的癌症护理:改善卡波西肉瘤结局的策略(SIKO),一项前瞻性基于社区的阶梯式楔形集群随机试验。

Evaluation of a training intervention to improve cancer care in Zimbabwe: Strategies to Improve Kaposi Sarcoma Outcomes (SIKO), a prospective community-based stepped-wedge cluster randomized trial.

机构信息

University of Colorado School of Medicine, Aurora, Colorado, USA.

Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.

出版信息

J Int AIDS Soc. 2022 Aug;25(8):e25998. doi: 10.1002/jia2.25998.

DOI:10.1002/jia2.25998
PMID:36028920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9418419/
Abstract

INTRODUCTION

Most Zimbabweans access medical care through tiered health systems. In 2013, HIV care was decentralized to primary care clinics; while oncology care remained centralized. Most persons in Zimbabwe with Kaposi sarcoma (KS) are diagnosed late in their disease, and the prognosis is poor. Little is known about whether educational interventions could improve KS outcomes in these settings.

METHODS

Interventions to improve KS detection and management were evaluated at eight Zimbabwe primary care sites (four rural/four urban) that provided HIV care. Interventions included a standardized KS clinical evaluation tool, palliative care integration, standardized treatment and improved consultative services. Interventions were implemented between February 2013 and January 2016 using a randomized stepped-wedge cluster design. Sites were monitored for KS diagnosis rates and KS outcomes, including early diagnosis (T0 vs. T1 tumour stage), participant retention and mortality. Analyses controlled for within-clinic correlations.

RESULTS

A total of 1102 persons with suspected KS (96% HIV positive) were enrolled: 47% incident (new diagnosis), 20% prevalent (previous diagnosis) and 33% determined as not KS. Early (T0) diagnosis increased post-intervention, though not significant statistically (adjusted odds ratio [aOR] = 1.48 [95% confidence interval (95% CI): 0.66-3.79], p = 0.37). New KS diagnosis rates increased 103% (95% CI: 11-273%), p = 0.02) post-intervention; although paired with an increased odds of incorrectly diagnosing KS (aOR = 2.08 [95% CI: 0.33-3.24], p = 0.001). Post-intervention, non-significant decreases in 90-day return rates (adjusted hazard ratio [aHR] = 0.69 [95% CI: 0.38-1.45], p = 0.21) and survival (aHR = 1.36 [95% CI: 0.85-2.20], p = 0.20) were estimated.

CONCLUSIONS

KS training interventions at urban and rural Zimbabwe decentralized primary care clinics significantly increased overall and incorrect KS diagnosis rates, but not early KS diagnosis rates, 90-day return rates or survival.

摘要

简介

大多数津巴布韦人通过分层医疗系统获得医疗服务。2013 年,艾滋病毒治疗工作已下放至初级保健诊所;而肿瘤治疗仍集中于中心医院。津巴布韦大多数卡波西肉瘤(KS)患者在疾病晚期才被诊断出来,预后较差。关于教育干预措施是否能改善这些环境下 KS 的预后,目前知之甚少。

方法

在提供艾滋病毒护理的津巴布韦八个初级保健点(4 个农村/4 个城市)评估了改善 KS 检测和管理的干预措施。这些干预措施包括使用标准化 KS 临床评估工具、姑息治疗整合、标准化治疗和改善咨询服务。干预措施于 2013 年 2 月至 2016 年 1 月期间采用随机分阶段楔形集群设计实施。对各医疗点 KS 诊断率和 KS 结局进行监测,包括早期诊断(T0 期与 T1 期肿瘤分期)、参与者保留率和死亡率。分析时控制了诊所内相关性。

结果

共纳入 1102 例疑似 KS 患者(96% HIV 阳性):47%为新发病例(新诊断),20%为现患病例(以前诊断),33%为非 KS 病例。干预后早期(T0)诊断增加,但无统计学意义(校正比值比[aOR] = 1.48[95%可信区间(95%CI):0.66-3.79],p = 0.37)。新 KS 诊断率增加 103%(95%CI:11-273%),p = 0.02);但 KS 误诊的几率也相应增加(校正比值比[aOR] = 2.08[95%CI:0.33-3.24],p = 0.001)。干预后,90 天内复诊率(校正风险比[aHR] = 0.69[95%CI:0.38-1.45],p = 0.21)和生存率(aHR = 1.36[95%CI:0.85-2.20],p = 0.20)的降低均无统计学意义。

结论

在津巴布韦城乡的初级保健诊所开展 KS 培训干预措施显著增加了整体和错误 KS 诊断率,但并未增加早期 KS 诊断率、90 天内复诊率或生存率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57b/9418419/e783f038bcab/JIA2-25-e25998-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57b/9418419/fa49e8136c37/JIA2-25-e25998-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57b/9418419/13f9fba500b1/JIA2-25-e25998-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57b/9418419/de4b84fa2603/JIA2-25-e25998-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57b/9418419/f673f93d81de/JIA2-25-e25998-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57b/9418419/e783f038bcab/JIA2-25-e25998-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57b/9418419/fa49e8136c37/JIA2-25-e25998-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57b/9418419/13f9fba500b1/JIA2-25-e25998-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57b/9418419/de4b84fa2603/JIA2-25-e25998-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57b/9418419/f673f93d81de/JIA2-25-e25998-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57b/9418419/e783f038bcab/JIA2-25-e25998-g002.jpg

相似文献

1
Evaluation of a training intervention to improve cancer care in Zimbabwe: Strategies to Improve Kaposi Sarcoma Outcomes (SIKO), a prospective community-based stepped-wedge cluster randomized trial.评估一项培训干预措施,以改善津巴布韦的癌症护理:改善卡波西肉瘤结局的策略(SIKO),一项前瞻性基于社区的阶梯式楔形集群随机试验。
J Int AIDS Soc. 2022 Aug;25(8):e25998. doi: 10.1002/jia2.25998.
2
Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.与卡波西肉瘤相关的免疫重建炎症综合征:在非洲的发病率和死亡率高于英国。
AIDS. 2013 Jun 19;27(10):1603-13. doi: 10.1097/QAD.0b013e328360a5a1.
3
Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi.在马拉维农村地区,接受全身化疗和综合抗逆转录病毒治疗的成人HIV相关卡波西肉瘤患者取得了优异的临床疗效,并持续接受治疗。
J Int AIDS Soc. 2015 May 29;18(1):19929. doi: 10.7448/IAS.18.1.19929. eCollection 2015.
4
Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study.南部非洲接受抗反转录病毒治疗的 HIV 感染患者卡波西肉瘤发病率:一项前瞻性多队列研究。
J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):547-54. doi: 10.1097/QAI.0000000000000360.
5
Assessing the outcomes of HIV-infected persons receiving treatment for Kaposi sarcoma in Conakry-Guinea.评估在科纳克里-几内亚接受卡波西肉瘤治疗的 HIV 感染者的结局。
BMC Cancer. 2017 Dec 2;17(1):806. doi: 10.1186/s12885-017-3771-x.
6
Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.评估血浆人类疱疹病毒 8 型 DNA 作为津巴布韦艾滋病相关卡波西肉瘤抗逆转录病毒治疗期间临床结局的标志物。
Clin Infect Dis. 2010 Aug 1;51(3):342-9. doi: 10.1086/654800.
7
Relationship of vitamin D insufficiency to AIDS-associated Kaposi's sarcoma outcomes: retrospective analysis of a prospective clinical trial in Zimbabwe.维生素D缺乏与艾滋病相关卡波西肉瘤预后的关系:津巴布韦一项前瞻性临床试验的回顾性分析
Int J Infect Dis. 2014 Jul;24:6-10. doi: 10.1016/j.ijid.2014.02.006. Epub 2014 Apr 21.
8
AIDS-associated Kaposi sarcoma: outcomes after initiation of antiretroviral therapy at a university-affiliated hospital in urban Zimbabwe.艾滋病相关卡波西肉瘤:津巴布韦城市一所大学附属医院启动抗逆转录病毒治疗后的结果。
Int J Infect Dis. 2013 Oct;17(10):e902-6. doi: 10.1016/j.ijid.2013.04.011. Epub 2013 Jul 1.
9
A prospective study of clinical outcomes of HIV-associated and HIV-negative Kaposi sarcoma in Uganda.乌干达一项关于 HIV 相关与 HIV 阴性卡波西肉瘤临床结局的前瞻性研究。
AIDS. 2023 Jan 1;37(1):51-59. doi: 10.1097/QAD.0000000000003376. Epub 2022 Sep 2.
10
Kaposi sarcoma trends in Uganda and Zimbabwe: a sustained decline in incidence?乌干达和津巴布韦的卡波西肉瘤趋势:发病率持续下降?
Int J Cancer. 2013 Sep 1;133(5):1197-203. doi: 10.1002/ijc.28125. Epub 2013 Mar 8.

本文引用的文献

1
Kaposi Sarcoma as a Cutaneous Vasculitis Mimic: Diagnosis and Treatment.卡波西肉瘤伪装成皮肤血管炎:诊断与治疗
J Clin Aesthet Dermatol. 2019 Nov;12(11):23-26. Epub 2019 Nov 1.
2
Establishing a multidisciplinary AIDS-associated Kaposi's sarcoma clinic: Patient characteristics, management and outcomes.建立多学科艾滋病相关卡波西肉瘤诊所:患者特征、管理及结果。
S Afr Med J. 2018 Nov 26;108(12):1059-1065. doi: 10.7196/SAMJ.2018.v108i12.13202.
3
A retrospective review of patients with Kaposi's sarcoma in Botswana.回顾性分析博茨瓦纳卡波西肉瘤患者。
Int J Dermatol. 2019 Jun;58(6):707-712. doi: 10.1111/ijd.14305. Epub 2018 Nov 21.
4
HIV-associated Kaposi's sarcoma in Maputo, Mozambique: outcomes in a specialized treatment center, 2010-2015.莫桑比克马普托的人类免疫缺陷病毒相关卡波西肉瘤:2010 - 2015年一家专业治疗中心的治疗结果
Infect Agent Cancer. 2018 Jan 19;13:5. doi: 10.1186/s13027-018-0177-6. eCollection 2018.
5
Assessing the outcomes of HIV-infected persons receiving treatment for Kaposi sarcoma in Conakry-Guinea.评估在科纳克里-几内亚接受卡波西肉瘤治疗的 HIV 感染者的结局。
BMC Cancer. 2017 Dec 2;17(1):806. doi: 10.1186/s12885-017-3771-x.
6
Survival of patients with Kaposi's sarcoma in the South African antiretroviral treatment era: A retrospective cohort study.南非抗逆转录病毒治疗时代卡波西肉瘤患者的生存情况:一项回顾性队列研究。
S Afr Med J. 2017 Sep 22;107(10):871-876. doi: 10.7196/SAMJ.2017.v107i10.12362.
7
Differences in survival among adults with HIV-associated Kaposi's sarcoma during routine HIV treatment initiation in Zomba district, Malawi: a retrospective cohort analysis.马拉维松巴区成人在常规启动艾滋病毒治疗期间,与艾滋病毒相关的卡波西肉瘤患者的生存差异:一项回顾性队列分析。
Int Health. 2017 Sep 1;9(5):281-287. doi: 10.1093/inthealth/ihx027.
8
Nursing's Potential to Address the Growing Cancer Burden in Low- and Middle-Income Countries.护理在应对低收入和中等收入国家日益加重的癌症负担方面的潜力。
J Glob Oncol. 2016 Feb 3;2(3):154-163. doi: 10.1200/JGO.2015.001974. eCollection 2016 Jun.
9
Evaluation of a Predictive Staging Model for HIV-Associated Kaposi Sarcoma in Uganda.乌干达HIV相关卡波西肉瘤预测分期模型的评估
J Acquir Immune Defic Syndr. 2017 Apr 15;74(5):548-554. doi: 10.1097/QAI.0000000000001286.
10
Outcomes of HIV-positive patients lost to follow-up in African treatment programmes.非洲治疗项目中失访的艾滋病毒阳性患者的结局。
Trop Med Int Health. 2017 Apr;22(4):375-387. doi: 10.1111/tmi.12843. Epub 2017 Feb 20.